LAVA Therapeutics NV

Ownership Transactions Reported by 12 Insiders

Symbol
LVTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
Yalelaan 62, Utrecht, Netherlands

There are no Buy or Sell transactions made by insiders since 4/21/2024

LAVA Therapeutics NV executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cooperatieve Gilde Healthcare IV U.A. 10%+ Owner Jan 1, 2025
Versant Venture Capital VI, L.P. 10%+ Owner Jan 1, 2025
Jay T. Backstrom Director Feb 13, 2025
Mary E. Wadlinger Director Feb 13, 2025
Karen J. Wilson Director Feb 13, 2025
Stephen A. Hurly Chief Executive Officer, Director Feb 13, 2025
Peter A. Kiener Director Feb 13, 2025
Fred M. Powell Chief Financial Officer Feb 13, 2025
James Noble Director Feb 13, 2025
Christy J. Oliger Director Feb 13, 2025
Charles Q. Morris Chief Medical Officer Feb 13, 2025
Kapil Dhingra Director Feb 13, 2025

Recent Insider Transactions by Companies or Individuals for LAVA Therapeutics NV

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.